Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Modulation of Stress-Associated Chemosignals
NCT03265899Phase 1Completed
- Sponsor
- University Hospital Bonn
- Start
- Jul 2015
- Primary completion
- Nov 2016
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in anxiety disorder, sponsored by University Hospital Bonn. Primary endpoints: Forced-choice ratings of morphed emotional faces and Response time for facial stimuli ratings. Started Jul 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03265899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265899.